SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-155147
Filing Date
2024-06-05
Accepted
2024-06-05 16:21:59
Documents
15
Period of Report
2024-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d841277d8k.htm   iXBRL 8-K 36165
2 EX-99.1 d841277dex991.htm EX-99.1 13752
6 GRAPHIC g841277g0605224714217.jpg GRAPHIC 4263
  Complete submission text file 0001193125-24-155147.txt   185584

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20240605.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20240605_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20240605_pre.xml EX-101.PRE 11257
18 EXTRACTED XBRL INSTANCE DOCUMENT d841277d8k_htm.xml XML 3642
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 241022277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)